The Efficacy of Lacticum Acidum Homaccord in the Treatment of Chronic Tension-type Headaches
2 other identifiers
interventional
30
1 country
1
Brief Summary
Chronic tension-type headaches (CTTHs) affect 30-40% of the population and account for a number of absences from, and decreased performances at, work and school as well as recreational activities. CTTHs typically occur at least 15 times a month or at least every second day, and present as an achy or tight sensation that is felt around the head . The pain may last from 30 minutes to several days and varies in intensity . Conventional treatment is palliative, consisting of analgesics and non-steroidal anti-inflammatory drugs (NSAIDs), which may produce adverse effects and analgesic rebound headaches . Lacticum acidum 30CH is a homoeopathic remedy that has been shown to have potential benefits in the treatment of CTTHs . Homaccords are the preparation of one remedy in multiple increasing potencies in a single vehicle . There has been no research done to date on Lacticum acidum Homaccord in the treatment of CTTHs.The aim of this study is to determine the efficacy of Lacticum acidum Homaccord in the treatment of chronic tension-type headaches, using the modified Headache Diary and the Headache Disability Inventory.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_2
Started Apr 2014
Shorter than P25 for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2014
CompletedFirst Submitted
Initial submission to the registry
May 12, 2014
CompletedFirst Posted
Study publicly available on registry
May 14, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2014
CompletedMay 17, 2016
May 1, 2016
2 months
May 12, 2014
May 16, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
modified Headache Diary and the Headache Disability Inventory.
one month
Study Arms (2)
Lacticum acidum homaccord
EXPERIMENTALLacticum acidum homaccord 30 mL bottle of medicated sucrose pillules take 5 pillules of the medication in the morning and in the evening for 4 weeks
Placebo
PLACEBO COMPARATORUnmedicated sucrose pillules, take 5 pillules twice daily for 4 weeks
Interventions
Homeopathic remedy, made using sucrose pillules
Eligibility Criteria
You may qualify if:
- Are male or female participants between the ages of 18 and 45 years;
- Fit the diagnostic criteria for CTTHs: headache occurring for 15 days a month or more, for a period of more than 3 months a year and lasts for hours or may be continuous. The headache should have at least one of the following characteristics: 1. bilateral location; 2. pressing/tightening (non-pulsating) quality; 3. mild or moderate intensity, 4. aggravated by normal physical activities such as walking or climbing stairs; and at least one of the characteristics in the following categories: 5.1. photophobia, phonophobia or mild nausea, and 5.2. moderate or severe nausea or vomiting ; and
- Fit eight out of the twelve headache-related symptom criteria for Lacticum acidum .
You may not qualify if:
- Have history of headache or a change in their normal pattern or type of headache over the previous three months;
- Have had any head, neck or back injury in the previous month;
- Suffer from rheumatoid arthritis, a suspected tumour or vision problems;
- Use opioids or analgesics for more than 15 days a month, for more than three months a year;
- Use chronic medication such as corticosteroids, antidepressants, anti-hypertensives; and / or
- Are pregnant or breastfeeding.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UJ
Johannesburg, Gauteng, 2028, South Africa
Study Officials
- STUDY CHAIR
Radmila Razlog, M.Tech Hom
UJ
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr
Study Record Dates
First Submitted
May 12, 2014
First Posted
May 14, 2014
Study Start
April 1, 2014
Primary Completion
June 1, 2014
Study Completion
June 1, 2014
Last Updated
May 17, 2016
Record last verified: 2016-05
Data Sharing
- IPD Sharing
- Will not share